Noticias de Eulerpool Travere Therapeutics

Travere Therapeutics Noticias de Acciones

Travere Therapeutics es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Travere Therapeutics.

• 13 de junio ·

  Yahoo
  HC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI Breakthroughs
• 11 de junio ·

  Yahoo
  Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 15th International Podocyte Conference
• 10 de junio ·

  Yahoo
  Travere Therapeutics Launches "Play It Forward" Campaign to Celebrate the FSGS Community on Inaugural Awareness Day
• 23 de mayo ·

  Yahoo
  England's NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA nephropathy
• 15 de mayo ·

  Yahoo
  Travere Therapeutics Announces FDA Acceptance of sNDA for FILSPARI® (sparsentan) in FSGS
• 13 de mayo ·

  Yahoo
  Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results
• 29 de abril ·

  Yahoo
  Travere Therapeutics and CSL Vifor Announce Standard EU Approval of FILSPARI® (sparsentan) for IgA Nephropathy
• 29 de abril ·

  Yahoo
  CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy
• 24 de abril ·

  Yahoo
  Travere Therapeutics to Report First Quarter 2025 Financial Results
• 23 de abril ·

  Yahoo
  Exploring 3 High Growth Tech Stocks In The US Market